Search results :

Oxaliplatin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: L01XA03

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Neutropenia very common, 0% - 82.2% x x x x x x x x x x x x x x x x x x x
Constipation very common, 1% - 31% x x x x x x x x x x x x x x x x x x
Hepatic enzyme increased 1% - 34% x
Asthenia very common, 1% - 23.4% x x x x
Paraesthesia common — 0% - 92% x x x x x x x x x x x x x x x x x x x
Swelling very common x x x x x x x x x x x x x x
Tremor very common x x x x x
Urticaria very common x x x x x x x x x x x x x x x x x x
Redness very common x x x x x x x x x x x x x x
Conjunctivitis common — 1% - 15% x x x x x x x x x x x x x x x x x x
Nausea very common, 0.3% - 73.7% x x x x x x x x x x x x x x x x x x x
Leukopenia 0% - 35% x x x x x x x x x x x x x x x
Peripheral sensory neuropathy very common, 1% - 16% x x x x x x x x x x x x x x x x x x x
Diarrhoea postmarketing — 1.5% - 85.9% x x x x x x x x x x x x x x x x x x x
Arthralgia very common, 7% - 10% x x x x x x x x x x x x x x x x x x
Weight increased 1% - 10% x x x x x x x x x x x x x x
Mucosal inflammation very common, 0.1% - 42.1% x x x x x x x x x x x x x x x x x x x
Fatigue very common, 0% - 70.3% x x x x x x x x x x x x x x x x x x
Vomiting postmarketing — 0.5% - 88.9% x x x x x x x x x x x x x x x x x x x
Rigors very common, 6% - 9% x x x x x x x x x x x x x x x x x x
Abdominal pain very common, 1% - 31% x x x x x x x x x x x x x x x x x x
Eye disorder 5% - 18% x
Headache 1% - 13% x x x x x x x x x x x x x x x
Oedema peripheral 5% - 11% x x x x x x x x x x x x x x x
Lacrimation increased 5% - 18% x
Dizziness 7% - 8% x x x x x x x x x x x x x x x
Neuropathy 0% - 76% x x x x x x x x x x x x x x x x x
Rhinitis common — 0% - 8% x x x x x x x x x x x x x x x x x x
Lacrimation abnormal NOS 0% - 12% x x x x x x x x x x x x x x
Upper respiratory tract infection 4% - 7% x x x x x x x x x x x x x
Agranulocytosis 0% - 78.9% x x x x x x x x x x x x x x x x x x
Bronchospasm common x x x x x x
Dehydration very common, 3% - 11% x x x x x x x x x x x x x x x x x
Dysgeusia very common, 0% - 8% x x x x x x x x x x x x x x x x x x
Dyspepsia common, 0% - 10% x x x x x x x x x x x x x x x x x x
Rash common — 0% - 5% x x x x x x x x x x x x x x x x x x
Gastrointestinal haemorrhage common x x x x x x x x x x x x x x x x x
Hyperbilirubinaemia 4% - 20% x x x x x x x x x x x x x x
Hypertension rare, common x x x x x x x x x x x x x x x x x
Thrombosis very common, 0.1% - 6.5% x x x x x x x x x x x x x x x x x x
Trismus common x x x x x
Deep vein thrombosis common x x x
Chest pressure common x x x x
Thromboembolic event common x x x x x x x x x x x x x x x x
Flatulence 3% - 6% x x x x x x x x x x x x x x x
Insomnia 0% - 11% x x x x x x x x x x x x x x x
Alopecia common — 0% - 44.1% x x x x x x x x x x x x x x x x x x x
Anorexia very common, 1% - 20% x x x x x x x x x x x x x x x x x x
Back pain very common, 0% - 16% x x x x x x x x x x x x x x x x x x
Chest pain common, 1% - 5% x x x x x x x x x x x x x x x x x x
Infection very common, 0% - 31.6% x x x x x x x x x x x x x x x x x x x
Dyspnoea common, 1% - 13% x x x x x x x x x x x x x x x x x x
Anaemia very common, 0.1% - 85.2% x x x x x x x x x x x x x x x x x x x
Epistaxis very common, 0% - 12% x x x x x x x x x x x x x x x x x x
Hyperglycaemia 2% - 3% x x x x x x x x x x x x x x
Hypokalaemia postmarketing — 1% - 4% x x x x x x x x x x x x x x x x x x
Hypotension common, 3% x x x x x x x x x x x x x x x x x x
Pain very common, 1% - 14% x x x x x x x x x x x x x x x x x x
Stomatitis very common, 0% - 61.6% x x x x x x x x x x x x x x x x x x
Thrombocytopenia postmarketing — 0% - 77.4% x x x x x x x x x x x x x x x x x x x
Urinary tract infection 1% - 5% x x
Injection site reaction very common, 0% - 11.1% x x x x x x x x x x x x x x x x x x
Depression 0% - 5% x x x x x x x x x x x x x x
Anxiety 0% - 6% x x x x x x x x x x x x x x
Flushing 2% - 3% x x x x x x x x x x x x x x
Hyponatraemia 1% - 4% x x x x x x x x x x x x x x
Lymphopenia 1% - 2% x x x x x x x x x x x x x x
Pharyngitis 0% - 10% x x x x x x x x x x x x x x
Skin disorder 0.6% - 36% x x x x x x x x x x x x x x x x x x
Thromboembolism 1% - 8% x x x x x x x x x x x x x x
Myalgia 0% - 2% x x x x x x x x x x x x x x
Dysaesthesia common — 0% - 2% x x x x x x x x x x x x x x x x x x x
Sweating increased 0% - 8% x x x x x x x x x x x x x x
Sinusitis 0% - 4% x
Skin exfoliation 0% - 11% x
Phlebitis 0.1% - 6.5% x x x x
Laryngopharyngeal dysesthesia 0% - 38.2% x x x x
Cough very common, 0% - 13% x x x x x x x x x x x x x x x x x
Dysuria 0% - 2% x x x x x x x x x x x x x x
Oedema 1% - 13% x x x x x x x x x x x x x x
Body temperature increased very common, 0% - 36% x x x x x x x x x x x x x x x x x x x
Gastrooesophageal reflux disease 0% - 3% x x x x x x x x x x x x x x
Haematuria 0% - 4% x x x x x x x x x x x x x x
Hiccups common, 0% - 2% x x x x x x x x x x x x x x x x x
Hypersensitivity postmarketing, 0% - 10.3% x x x x x x x x x x x x x x x x x x x
Pollakiuria 1% x x x x x x x x x x x x x x
Sensory disturbance 0% - 1% x x x x x x x x x x x x x x
Hypoalbuminaemia 0% - 2% x x x x x x x x x x x x x x
Febrile neutropenia common, 0% - 14% x x x x x x x x x x x x x x x x x x x
Abnormal vision 0% - 1% x x x x x x x x x x x x x x
Ototoxicity uncommon x x x x
Phosphatase alkaline increased 1% - 20% x x x x x x x x x x x x x x
Neutropenic sepsis 0.1% - 1.1% x x x x x x x x x x x x x x x x x
Anaphylactic shock postmarketing — 0.5-2% x x x x x x x x x x x x x x x x x x x
Haemolytic anaemia postmarketing, rare x x x x x x x x x x x x x x
Autoimmune haemolytic anaemia rare x x x x
Angioedema postmarketing, common x x x x x x x x x x x x x x x x x x
Coagulopathy postmarketing x x x x x x x x x x x x x x
Colitis postmarketing, rare x x x x x x x x x x x x x x x x x x
Deafness postmarketing, rare x x x x x x x x x x x x x x x x x x
Dysarthria postmarketing, rare x x x x x x x x x x x x x x x x x x
Fasciculation postmarketing x x x x x x x x x x x x x x
Fibrosis very rare, postmarketing x x x x x x x x x x x x x x x x x x
Haemolytic uraemic syndrome postmarketing, rare x x x x x x x x x x x x x x
Haemorrhage postmarketing x x x x x x x x x x x x x x
Venoocclusive liver disease very rare, postmarketing x x x x x x x x x x x x x x x x x x
Intestinal obstruction postmarketing, very common x x x x x x x x x x x x x x x x x x
Nephropathy postmarketing x x x x x x x x x x x x x
Renal failure acute postmarketing x x x x x x x x x x x x x x x x x
Nephrosis lower nephron postmarketing x x x x x x x x x x x x x x x
Laryngospasm postmarketing x x x x x x x x x
Optic neuritis postmarketing, rare x x x x x x x x x x x x x x x x x x
Pancreatitis postmarketing, rare x x x x x x x x x x x x x x x x
Neuropathy peripheral postmarketing, common x x x x x x x x x x x x x x x x
Pulmonary fibrosis postmarketing, rare x x x x x x x x x x x x x x x x x x
Convulsion postmarketing x x x x x x x x x x x x x x x x
Disorder sight postmarketing x x x x x x x x x x x x x x
Acute interstitial nephritis postmarketing x x x x x x x x x x x x x x x
Cranial nerve paralysis postmarketing x x x x x x x x x x x x x
Optic ischaemic neuropathy rare x
Interstitial lung disease postmarketing, rare x x x x x x x x x x x x x x x x x x
Metabolic acidosis postmarketing, very common x x x x x x x x x x x x x x x x x x
Red blood cell disorders postmarketing x x x x x x x x x x x x x x
Visual acuity reduced rare x x x x
Diarrhoea, Clostridium difficile postmarketing, rare x x x x x x x x x x x x x x x x x
Lhermitte's sign postmarketing — very common x x x x x x x x x x x x x x x x x x
Venoocclusive disease very rare, postmarketing x x x x x x x x x x x x x x
Ileus postmarketing, very common x x x x x x x x x x x x x x x x x x
Posterior reversible encephalopathy syndrome very rare — rare x x x x x x x x x x x x x
Guillain-Barre syndrome very rare x
Nodular regenerative hyperplasia very rare x x x x x
Portal hypertension very rare x x x x x
Liver disorder very rare x
Peliosis hepatis very rare x x x
Purpura very rare x x x x x x x x x x x x x x x
Rhabdomyolysis very rare x
Transaminases increased very rare x x x
Renal tubular necrosis very rare x x x x
Aphasia x
Aphonia x
Ascites x x x x x x x x x x x x x x
Ataxia x x x x x x x x x x x x x x x x x x
Mental disorder x x
Cardiovascular disorder x
Cellulitis x
Cerebral infarction x x x x x x x x x x x x x
Connective tissue disorder x x
Contusion x
Cyanosis x x x x x
Dysphagia x x x x x
Diplopia x
Extravasation x x x x x x x x x x x x x x x
Facial pain x
Gastrointestinal disorder x x
Gingivitis x x x x x x x x x x x x x
Haematemesis x
Haemolysis x x x x
Haemoptysis x x x x x x x x x x x x x x
Haemorrhoids x x x x x x x x x x x x x
Hepatitis x
Hoarseness x
Hypoaesthesia x x x x x
Hypocalcaemia x x x x x x x x x x x x x x
Immune system disorder x
Inflammation x x x
Lethargy x
Mediastinal disorder x
Melaena x x x x x x x x x x x x x x
Metabolic disorder x
Cramp muscle x
Musculoskeletal disorder x
Myoclonus x x x x x
Nasopharyngitis x
Necrosis x x x x x x x x x x x x x x x
Nephritis interstitial x x
Nervous system disorder x x
Nervousness x x x x x x x x x x x x x
Neuralgia 0% - 1% x x x x x x x x x x x x x x
Pain in extremity x
Pneumonia x x x x x x x x x x x x x x
Proctitis x x x x x x x x x x x x x
Pruritus x x x x x x x x x x x x x x x
Proctalgia x x x x x x x x x x x x x x
Scotoma x
Muscle spasms x x x x x
Stevens-Johnson syndrome x x x x x x x x x x x x x
Stridor x
Suicide x x x x x x x x x x x x x
Sweating x x x x x x x x x x x x x x
Syncope x x x x x x x x x x x x x
Tachycardia x x x x x x x x x x x x x x
Thrombophlebitis x
Trigeminal neuralgia x
Urinary incontinence x x x x x x x x x x x x x
Urinary tract disorder x
Angiopathy x x x x
Vertigo x x x x x x x x x x x x x x
Vocal cord paralysis x
Weight decreased x x x x x x x x x x x x x x x
Wheezing x
Dry mouth x x x x x x x x x x x x x x x
Chills x
Hepatic failure x
Mouth ulceration x
Creatinine increased x x x x x x x x x x x x x
Hypomagnesaemia x
Accidental injury x
Muscular weakness x x x x x x x x x x x x x
Bone pain x x x x x x x x x x x x x x
Eye pain x
Prothrombin level increased x x x x x x x x x x x x x
Dry skin x x x x x x x x x x x x x x x
Malnutrition x x
Unspecified disorder of skin and subcutaneous tissue x x
Muscle twitching x x x x x
Chest tightness x x x x x
Decreased appetite x
Abdominal pain upper x
Rectal tenesmus x x x x x x x x x x x x x x
Disorientation x
Discomfort x x x x x
Nail changes x x x x x x x x x x x x x x
Rash erythematous x x x x x x x x x x x x x x
Neurological symptom x x x x x x x x x x x x x x x x x x
Neurotoxicity x x x x x
Muscle contractions involuntary x x x x x x x x x x x x x x x x x x
Hepatotoxicity x x x x x x x x x x x x x
Leg edema x
Pain in jaw x
Mucosal ulceration x
Sensory ataxia x
Disease progression x
Sepsis x x x x x x x x x x x x x x
Rectal haemorrhage x x x x x x x x x x x x x x
Hepatobiliary disease x
Uraemic syndrome x x x
Anxiety depression x
Anaphylactoid reaction x
Electrolyte imbalance x
Enlargement abdomen x x x x x x x x x x x x x
Lacrimation x x x x x x x x x x x x x x
Respiratory distress x x x x x
Coordination abnormal x x x x x
Choking sensation x x x x x
Gait disturbance x x x x x
Balance disorder x x x x x
Hot flush x x x x x x x x x x x x x
Catheter infection x x x x x x x x x x x x x x
Infestation NOS x
Blood and lymphatic system disorders x x
Anaemias haemolytic immune x
Advanced cancer x x x x
Pulmonary toxicity x x x x x x x x x x x x x
Dysphasia x x x x x x x x x x x x x
Temperature intolerance x
Unspecified disorder of autonomic nervous system x
Rhinorrhoea x
Dysaesthesia pharynx x
Dysphonia x x
Eosinophilic pneumonia x x x x x x x x x x x x x
Oropharyngeal pain x
Rhinitis allergic x x x x x x x x x x x x x x
Abdominal aortic rupture x x x x x x x x x x x x x
Somnolence x x x x x x x x x x x x x
Cerebral haemorrhage x x x x x x x x x x x x x
Metastatic neoplasm x x x x x x x x x x x x
Vaginal haemorrhage x x x x x x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Oxaliplatin

Side effects:24
Source:BC Cancer

ELOXATIN / Eloxatin, Concentrate for infusion

Side effects:103
Source:Medsafe

Oxaliplatin / OXALIPLATIN

Side effects:104
Source:medicines.org.au

Oxaliplatin concentrated solution for injection / ELOXATIN

Side effects:145
Source:medicines.org.au

OXALIPLATIN / ELOXATIN

Side effects:159
Source:FDA

OXALIPLATIN

Side effects:160
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:161
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:161
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:161
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:162
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:162
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:162
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:162
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:163
Source:FDA Structured Product Label

oxaliplatin

Side effects:163
Source:FDA Structured Product Label

oxaliplatin

Side effects:163
Source:FDA Structured Product Label

OXALIPLATIN

Side effects:163
Source:FDA Structured Product Label

OXALIPLATIN / ELOXATIN

Side effects:202
Source:Health Canada

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label